TARSUS PHARMACEUTICALS INC.

■ FOUNDED: 2016

■ CEO: Bobak Azamian

■ HEADQUARTERS: Irvine

■ BUSINESS: pharmaceuticals, therapeutics

■ Q1 LOSS: 98 cents per share

(vs. expected 87-cent loss)

■ EMPLOYEES: 46

■ NOTABLE: raised $75.6M in an oversubscribed public offering; submitting a New Drug Application to the FDA this year